Skip to main content
. 2013 May 13;110(22):9084–9089. doi: 10.1073/pnas.1300595110

Fig. 4.

Fig. 4.

Identification of CpaA as an additional c-di-AMP target protein. (A) Schematic representation of the predicted K+ or Na+ antiporter CpaA (SAUSA300_0911), containing an N-terminal transmembrane (yellow) and cytoplasmically located RCK_N (blue) and RCK_C (orange) domains. (B) DRaCALAs with 32P-labeled c-di-AMP and E. coli extracts prepared from the vector control strain (pET28b) or strains overproducing His-CpaASA-402-614 (RCK_N and RCK_C) or His-CpaASA-513-614 (RCK_C). Cold c-di-AMP was added as a competitor where indicated.